Homoeopathy as adjuvant in management of Covid-19 infection
|Type of Trial||Interventional|
|Type of Study||Homeopathy|
|Study Design||Randomized, Parallel Group, Placebo Controlled Trial|
|Public Title of Study||Homoeopathy as adjuvant in management of Covid-19 infection|
|Scientific Title of Study||Effect of adjuvant homoeopathy with standard treatment protocol in management of covid-19: a randomised, open label, placebo controlled, parallel group study|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|Name||Prof Dr Pradeep Kumar Gupta|
|Affiliation||Naiminath Homoeopathic Medical College, Hospital and Research Centre|
|Health Condition / Problems Studied|
|Method of Generating Random Sequence||Computer generated randomization|
|Target Sample Size||Total Sample Size="100"|
Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials"
The results of the study will be able to predict the role of add on homoeopathic treatment for management of Covid-19 infected. In the absence any known anti-viral and vaccine the positive results of this study will decrease the morality and morbidity due to this pandemic. Further the cost-effectiveness of homoeopathy will enable developing countries in controlling such deadly disease effectively.